Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.10503 | 67 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.31368 | 69 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.17291 | 68 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.0937 | 67 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.12153 | 68 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.19727 | 68 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.66016 | 60 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.13949 | 68 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.07086 | 67 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.14854 | 68 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.19471 | 68 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.2033 | 68 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.18946 | 68 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.31125 | 70 |